Balyasny Asset Management

Balyasny Asset Management’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Balyasny Asset Management’s Portfolio EIDX Stock Details EIDX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell
2020 Q4	$39.1M	Buy
2018 Q4	–	Sell
2018 Q3	$320K	Sell
2018 Q2	$1.64M	Buy